ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
종목 코드 CLPT
회사 이름Clearpoint Neuro Inc
상장일Jul 03, 2019
CEOMr. Joseph Michael Burnett
직원 수115
유형Ordinary Share
회계 연도 종료Jul 03
주소120 S. Sierra Avenue
도시SOLANA BEACH
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호92075
전화19499006833
웹사이트https://www.clearpointneuro.com/
종목 코드 CLPT
상장일Jul 03, 2019
CEOMr. Joseph Michael Burnett
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.

데이터 없음